Citation

Heightman TD, Berdini V, Braithwaite H, Buck IM, Cassidy M, Castro J, Courtin A, Day JEH, East C, Fazal L, Graham B, Griffiths-Jones CM, Lyons JF, Martins V, Muench S, Munck JM, Norton D, O'Reilly M, Palmer N, Pathuri P, Reader M, Rees DC, Rich SJ, Richardson C, Saini H, Thompson NT, Wallis NG, Walton H, Wilsher NE, Woolford AJ, Cooke M, Cousin D, Onions S, Shannon J, Watts J, Murray CW.: Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J Med Chem, Volume 61 (11), 2018

Authors

Berdini V, Braithwaite H, Buck IM, Cassidy M, Castro J, Cooke M, Courtin A, Cousin D, Day JEH, East C, Fazal L, Graham B, Griffiths-Jones CM, Heightman TD, Lyons JF, Martins V, Muench S, Munck JM, Murray CW., Norton D, O'Reilly M, Onions S, Palmer N, Pathuri P, Reader M, Rees DC, Rich SJ, Richardson C, Saini H, Shannon J, Thompson NT, Wallis NG, Walton H, Watts J, Wilsher NE, Woolford AJ

Journal

J Med Chem

Year

2018

DOI

10.1021/acs.jmedchem.8b00421

PubMed

29775310

Machine-readable

REST APIRDF